Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid

By Pittman P.R.   Hack D.   Mangiafico J.   Gibbs P.   McKee K.T.   Friedlander A.M.   Sjogren M.H.  

Vaccine, Vol. 20, Iss. 16, 2002-05 ,pp. : 2107-2115

Elsevier

Access to resources Recommend Favorite

Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid

By Isaka M.   Yasuda Y.   Kozuka S.   Taniguchi T.   Miura Y.   Matano K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 944-948

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults

By Kotloff K.L.   Fattom A.   Basham L.   Hawwari A.   Harkonen S.   Edelman R.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 446-450

Elsevier

Access to resources Recommend Favorite

The immunogenicity in humans of a botulinum type F vaccine

By Montgomery V.A.   Makuch R.S.   Brown J.E.   Hack D.C.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 728-735

Elsevier

Access to resources Recommend Favorite

Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model

By Devi S.J.N.  

Vaccine, Vol. 14, Iss. 9, 1996-06 ,pp. : 841-844

Elsevier

Access to resources Recommend Favorite